Does NIVOLUMAB Cause Rash maculo-papular? 432 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 432 reports of Rash maculo-papular have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.5% of all adverse event reports for NIVOLUMAB.
432
Reports of Rash maculo-papular with NIVOLUMAB
0.5%
of all NIVOLUMAB reports
45
Deaths
263
Hospitalizations
How Dangerous Is Rash maculo-papular From NIVOLUMAB?
Of the 432 reports, 45 (10.4%) resulted in death, 263 (60.9%) required hospitalization, and 40 (9.3%) were considered life-threatening.
Is Rash maculo-papular Listed in the Official Label?
Yes, Rash maculo-papular is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which NIVOLUMAB Alternatives Have Lower Rash maculo-papular Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE